Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.
Danqing KongYun LiChengcheng FuMengjia HouLingzhi YanJingjing ShangZhaoyue WangJie YinZiqiang YuDepei WuPublished in: Leukemia & lymphoma (2021)